117 related articles for article (PubMed ID: 7726141)
1. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
Charpin C; Devictor B; Bergeret D; Andrac L; Boulat J; Horschowski N; Lavaut MN; Piana L
Am J Clin Pathol; 1995 Apr; 103(4):443-8. PubMed ID: 7726141
[TBL] [Abstract][Full Text] [Related]
2. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
3. p53 quantitative immunocytochemical analysis in breast carcinomas.
Charpin C; DeVictor B; Andrac L; Amabile J; Bergeret D; LaVaut MN; Allasia C; Piana L
Hum Pathol; 1995 Feb; 26(2):159-66. PubMed ID: 7860046
[TBL] [Abstract][Full Text] [Related]
4. VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Andrac L; Horschowski N; Choux R; Lavaut MN
Hum Pathol; 1998 Sep; 29(9):896-903. PubMed ID: 9744304
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.
Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
J Pathol; 1993 Aug; 170(4):463-70. PubMed ID: 8410496
[TBL] [Abstract][Full Text] [Related]
6. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Lavaut MN; Allasia C
Br J Cancer; 1997; 76(3):340-6. PubMed ID: 9252201
[TBL] [Abstract][Full Text] [Related]
7. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.
Charpin C; Garcia S; Bouvier C; Martini F; Andrac L; Bonnier P; Lavaut MN; Allasia C
Am J Clin Pathol; 1997 May; 107(5):534-41. PubMed ID: 9128265
[TBL] [Abstract][Full Text] [Related]
8. VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Charpin C; Garcia S; Bergeret D; Andrac L; Horschowski N; Choux R; Lavaut MN
Br J Cancer; 1998 Jun; 77(12):2274-80. PubMed ID: 9649145
[TBL] [Abstract][Full Text] [Related]
9. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut MN; Allasia C
Hum Pathol; 1997 Mar; 28(3):289-96. PubMed ID: 9042792
[TBL] [Abstract][Full Text] [Related]
10. Quantitative imaging of ps2 immunocytochemical assays in breast carcinomas.
Charpin C; Devictor B; Bonnier P; Andrac L; Boulat J; Lavaut M; Allasia C; Piana L
Int J Oncol; 1993 Mar; 2(3):443-8. PubMed ID: 21573575
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.
Charpin C; Bonnier P; Khouzami A; Vacheret H; Andrac L; Lavaut MN; Allasia C; Piana L
Anticancer Res; 1992; 12(3):591-7. PubMed ID: 1352440
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin quantitative immunocytochemical assays in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut M
J Pathol; 1997 Mar; 181(3):294-300. PubMed ID: 9155715
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.
Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
Breast Cancer Res Treat; 1993; 25(3):203-10. PubMed ID: 8369521
[TBL] [Abstract][Full Text] [Related]
16. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Charpin C; Bergeret D; Garcia S; Andrac L; Martini F; Horschowski N; Choux R; Lavaut MN
Int J Oncol; 1998 May; 12(5):1041-8. PubMed ID: 9538126
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Clin Oncol; 1998 Jun; 16(6):2025-31. PubMed ID: 9626199
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].
Charpin C; Martin PM; Andrac L; Lavaut MN; Vacheret H; Habib MC; Toga M
Ann Pathol; 1988; 8(3):196-210. PubMed ID: 3178938
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.
Charpin C; Garcia S; Bouvier C; Martini F; Lavaut M; Allasia C; Bonnier P; Andrac L
J Clin Pathol; 1997 Jul; 50(7):586-90. PubMed ID: 9306940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]